The biopharmaceutical company posted adjusted earnings per share of $0.43, surpassing the analyst consensus of $0.11 by $0.32. Revenue for the quarter came in at $59.1 million, beating expectations of ...

The company posted adjusted earnings per share of $0.04 for the fourth quarter, beating the analyst estimate of -$0.01. Revenue came in at $126.7 million, surpassing the consensus forecast of $109.6 ...

Definitive Healthcare’s Q4 net loss ballooned to $84.7 million, or 136% of revenue, compared to a $13.4 million loss in the same quarter last year. The company attributed $97.1 million of the loss to ...

A mega wave of regional economic data breaks on Asian markets on Friday, with investors already bracing for a nervous end to the month as they weigh up tariff threats from Washington, further signs of ...